Mary Tolan

Articles

Are Outcomes-Based Deals Only a Band-Aid for High Drug Prices?

Pharmaceutical Executive

Outcomes-based contracts seem to have the potential to make drugs more affordable, but not without mutually-beneficial, data-driven arrangements.